News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cephalon, Inc. (CEPH) Probed by Department of Justice for Treanda (CEPH)



7/12/2011 7:09:21 AM

The U.S. Justice Department has asked Cephalon Inc. (CEPH) about documents relating to alleged off-label promotion of its Treanda treatment for chronic lymphocytic leukemia, the pharmaceutical industry news site Pharmalot.com reported Monday. The June request to the Pennsylvania-based drug maker concerned first-line treatment of non-Hodgkin's lymphoma, for which Treanda isn't approved, according to sources familiar with the request. Also requested were clinical studies that could be used to support off-label use before the studies were completed or submitted for review by the U.S. Food and Drug Administration.

Read at Nasdaq
Read at Investors


comments powered by Disqus
Nasdaq
Investors
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES